Indonesia Gene Synthesis Research Use Market Report Size Share Growth Drivers Trends Opportunities & Forecast 2025–2030
Description
Indonesia Gene Synthesis Research Use Market Overview
The Indonesia Gene Synthesis Research Use Market is valued at USD 140 million, based on a five-year historical analysis. This valuation is consistent with Indonesia’s position as an emerging, high?growth country market within the broader Asia–Pacific gene synthesis landscape, where Indonesia is highlighted as one of the key developing demand hubs alongside India, China, and Taiwan. This growth is primarily driven by advancements in biotechnology, increasing research activities in genomics, and the rising demand for synthetic biology applications in academic, clinical research, vaccine development, and industrial biotechnology. The market is further supported by the growing number of academic and research institutions focusing on genetic research and development, as well as increased adoption of gene synthesis services by local CROs, diagnostic labs, and biopharmaceutical manufacturers. Key players in this market are concentrated in major cities such as Jakarta, Bandung, and Surabaya. Jakarta, being the capital, hosts numerous research institutions and biotechnology companies and serves as a primary hub for genomics, molecular diagnostics, and contract research services. Bandung is known for its academic excellence in life sciences and pharmaceutical manufacturing, anchored by institutions and companies such as PT Bio Farma (Persero). Surabaya, as a growing industrial hub, is also contributing to the market's expansion through increased investments in biotechnology, clinical laboratories, and university?linked research centers that utilize gene synthesis and related DNA technologies for applied R&D. In 2023, the Indonesian government implemented a regulation aimed at promoting biotechnology research and development. This regulation is aligned with instruments such as the Presidential Regulation No. 78 of 2023 on the National Research and Innovation Priority, issued by the Government of Indonesia, which mandates priority funding for health, vaccines, genomics, and biotechnology?oriented research programs. Within this policy framework, competitive research grants and innovation funding schemes administered by the National Research and Innovation Agency (BRIN) and related ministries collectively provide public support equivalent to more than USD 20 million for molecular biology, genomics, and gene?related research projects, encouraging collaboration between public and private sectors to enhance the country's capabilities in genetic research and innovation.
Indonesia Gene Synthesis Research Use Market Segmentation
By Product & Service: The market is segmented into various products and services that cater to the diverse needs of researchers and institutions. The subsegments include Gene Synthesis Services, Gene Synthesis Kits & Reagents, Synthetic Genes, Gene Fragments & Oligonucleotides (Research Use), Plasmid Constructs, and Others. Among these, Gene Synthesis Services dominate the market due to their essential role in facilitating research and development in genomics and synthetic biology, especially for users that lack in?house synthesis infrastructure. The increasing demand for customized gene synthesis solutions, rapid turnaround times, and reliable quality control—driven by applications in vaccine development, assay development, and functional genomics—is driving growth in this subsegment. By Application: The applications of gene synthesis in Indonesia are diverse, including Basic Genomics & Functional Genomics Research, Synthetic Biology & Metabolic Engineering, Gene & Cell Therapy Research (Non-clinical), Vaccine & Biologics R&D, Agricultural & Industrial Biotechnology Research, Diagnostics & Assay Development Research, and Others. This structure is consistent with global and Asia–Pacific gene synthesis usage patterns, where research and diagnostic applications, vaccine and biologics development, and agriculture/industrial biotech are key demand drivers. The Basic Genomics & Functional Genomics Research segment is currently leading the market, driven by the increasing focus on understanding genetic functions and their implications in health and disease, as well as broader adoption of next?generation sequencing, CRISPR?based tools, and omics?driven discovery research in Indonesian universities, research institutes, and reference laboratories.
Indonesia Gene Synthesis Research Use Market Market Opportunities
The Indonesia Gene Synthesis Research Use Market is characterized by a dynamic mix of regional and international players. Leading participants such as PT Genetika Science Indonesia, PT Bio Farma (Persero), PT Prodia Stem Cell Indonesia, PT Kalbe Farma Tbk (Kalbe Genomics & Biologics Units), PT Eijkman Institute for Molecular Biology, PT Nusantics, PT IndoGen Biotech, PT Genomics Indonesia, PT Bioteknologi Indonesia, PT Medisafe Technologies (Medisyn), PT Bioinformatics Indonesia, PT Genomik Solidaritas Indonesia (GSI Lab), PT Biogen Scientific, PT Genetika Medika, Selected International Gene Synthesis Providers Active in Indonesia contribute to innovation, geographic expansion, and service delivery in this space.
PT Genetika Science Indonesia
2003 Jakarta, Indonesia
PT Bio Farma (Persero)
1890 Bandung, Indonesia
PT Prodia Stem Cell Indonesia
2012 Jakarta, Indonesia
PT Kalbe Farma Tbk
1966 Jakarta, Indonesia
PT Eijkman Institute for Molecular Biology
1992 Jakarta, Indonesia
Company
Establishment Year
Headquarters
Group Size (Large, Medium, or Small as per industry convention) Indonesia Gene Synthesis Research Use Revenue (USD, Latest Year)
3-year Revenue CAGR in Indonesia Gene Synthesis Research Use (%)
Indonesia Market Share (%)
R&D Intensity (% of Revenue Spent on R&D)
Number of Active Research Customers in Indonesia
Indonesia Gene Synthesis Research Use Market Industry Analysis
Growth Drivers
Increasing Demand for Synthetic Biology Applications: The Indonesian biotechnology sector is experiencing a surge in demand for synthetic biology applications, driven by a growing need for innovative solutions in agriculture and healthcare. In future, the biotechnology sector is projected to contribute approximately IDR 57.5 trillion to the national economy, reflecting a 15% increase from the previous period. This growth is fueled by advancements in genetic engineering, which enable the development of crops with enhanced traits and personalized medical therapies, thereby expanding the market for gene synthesis. Advancements in Gene Editing Technologies: The rapid evolution of gene editing technologies, particularly CRISPR, is a significant growth driver for the gene synthesis market in Indonesia. In future, investments in gene editing research are expected to reach IDR 12 trillion, a 20% increase from the previous period. These advancements facilitate precise modifications in genetic material, enhancing research capabilities in various fields, including agriculture and medicine, and driving demand for gene synthesis services and products. Rising Investment in Biotechnology Research: Indonesia is witnessing a notable increase in investment in biotechnology research, with government funding projected to exceed IDR 10 trillion in future. This represents a 25% rise compared to the previous period. Such investments are aimed at fostering innovation and supporting research institutions, which are crucial for the development of gene synthesis technologies. The influx of capital is expected to enhance the capabilities of local firms, thereby stimulating market growth and competitiveness.
Market Challenges
High Costs Associated with Gene Synthesis: One of the primary challenges facing the gene synthesis market in Indonesia is the high cost of synthesis services, which can reach up to IDR 1.15 billion for complex projects. This financial barrier limits access for smaller research institutions and startups, hindering innovation. As the market evolves, addressing these cost issues will be essential for broadening participation and fostering a more inclusive biotechnology ecosystem. Regulatory Hurdles in Biotechnology: The regulatory landscape for biotechnology in Indonesia presents significant challenges, with compliance costs estimated at IDR 600 million per project. These hurdles can delay research and development timelines, discouraging investment in gene synthesis initiatives. Navigating the complex regulatory environment requires substantial resources, which can be particularly burdensome for emerging biotech firms, potentially stifling innovation and market growth.
Indonesia Gene Synthesis Research Use Market Future Outlook
The future of the gene synthesis market in Indonesia appears promising, driven by ongoing advancements in biotechnology and increasing collaboration between research institutions and private firms. As the government continues to support biotech initiatives, the market is likely to see enhanced innovation and the development of cost-effective synthesis methods. Additionally, the integration of artificial intelligence in gene synthesis processes is expected to streamline operations, further propelling market growth and expanding applications across various sectors.
Market Opportunities
Expansion of Research Institutions: The establishment of new research institutions in Indonesia presents a significant opportunity for the gene synthesis market. With an expected increase of 30% in research facilities in future, these institutions will drive demand for gene synthesis services, fostering innovation and collaboration within the biotechnology sector. Collaborations with International Biotech Firms: Forming partnerships with international biotech firms can enhance local capabilities and access to advanced technologies. Such collaborations are projected to increase by 40% in future, providing Indonesian companies with the expertise and resources needed to compete globally, thereby expanding the gene synthesis market.
Please Note: The report will take approximately 4–6 weeks to prepare and deliver.
Update cycle typically involves:
Dataset refresh & triangulation from credible public sources + paid databases where applicable.
Competitive mapping (platform coverage, business model, revenue/traffic proxies where available, key vertical splits)
Validation pass to ensure numbers are directionally consistent (and avoid “stale” assumptions)
Finalizing the PDF + Excel with clear assumptions and definitions.
The Indonesia Gene Synthesis Research Use Market is valued at USD 140 million, based on a five-year historical analysis. This valuation is consistent with Indonesia’s position as an emerging, high?growth country market within the broader Asia–Pacific gene synthesis landscape, where Indonesia is highlighted as one of the key developing demand hubs alongside India, China, and Taiwan. This growth is primarily driven by advancements in biotechnology, increasing research activities in genomics, and the rising demand for synthetic biology applications in academic, clinical research, vaccine development, and industrial biotechnology. The market is further supported by the growing number of academic and research institutions focusing on genetic research and development, as well as increased adoption of gene synthesis services by local CROs, diagnostic labs, and biopharmaceutical manufacturers. Key players in this market are concentrated in major cities such as Jakarta, Bandung, and Surabaya. Jakarta, being the capital, hosts numerous research institutions and biotechnology companies and serves as a primary hub for genomics, molecular diagnostics, and contract research services. Bandung is known for its academic excellence in life sciences and pharmaceutical manufacturing, anchored by institutions and companies such as PT Bio Farma (Persero). Surabaya, as a growing industrial hub, is also contributing to the market's expansion through increased investments in biotechnology, clinical laboratories, and university?linked research centers that utilize gene synthesis and related DNA technologies for applied R&D. In 2023, the Indonesian government implemented a regulation aimed at promoting biotechnology research and development. This regulation is aligned with instruments such as the Presidential Regulation No. 78 of 2023 on the National Research and Innovation Priority, issued by the Government of Indonesia, which mandates priority funding for health, vaccines, genomics, and biotechnology?oriented research programs. Within this policy framework, competitive research grants and innovation funding schemes administered by the National Research and Innovation Agency (BRIN) and related ministries collectively provide public support equivalent to more than USD 20 million for molecular biology, genomics, and gene?related research projects, encouraging collaboration between public and private sectors to enhance the country's capabilities in genetic research and innovation.
Indonesia Gene Synthesis Research Use Market Segmentation
By Product & Service: The market is segmented into various products and services that cater to the diverse needs of researchers and institutions. The subsegments include Gene Synthesis Services, Gene Synthesis Kits & Reagents, Synthetic Genes, Gene Fragments & Oligonucleotides (Research Use), Plasmid Constructs, and Others. Among these, Gene Synthesis Services dominate the market due to their essential role in facilitating research and development in genomics and synthetic biology, especially for users that lack in?house synthesis infrastructure. The increasing demand for customized gene synthesis solutions, rapid turnaround times, and reliable quality control—driven by applications in vaccine development, assay development, and functional genomics—is driving growth in this subsegment. By Application: The applications of gene synthesis in Indonesia are diverse, including Basic Genomics & Functional Genomics Research, Synthetic Biology & Metabolic Engineering, Gene & Cell Therapy Research (Non-clinical), Vaccine & Biologics R&D, Agricultural & Industrial Biotechnology Research, Diagnostics & Assay Development Research, and Others. This structure is consistent with global and Asia–Pacific gene synthesis usage patterns, where research and diagnostic applications, vaccine and biologics development, and agriculture/industrial biotech are key demand drivers. The Basic Genomics & Functional Genomics Research segment is currently leading the market, driven by the increasing focus on understanding genetic functions and their implications in health and disease, as well as broader adoption of next?generation sequencing, CRISPR?based tools, and omics?driven discovery research in Indonesian universities, research institutes, and reference laboratories.
Indonesia Gene Synthesis Research Use Market Market Opportunities
The Indonesia Gene Synthesis Research Use Market is characterized by a dynamic mix of regional and international players. Leading participants such as PT Genetika Science Indonesia, PT Bio Farma (Persero), PT Prodia Stem Cell Indonesia, PT Kalbe Farma Tbk (Kalbe Genomics & Biologics Units), PT Eijkman Institute for Molecular Biology, PT Nusantics, PT IndoGen Biotech, PT Genomics Indonesia, PT Bioteknologi Indonesia, PT Medisafe Technologies (Medisyn), PT Bioinformatics Indonesia, PT Genomik Solidaritas Indonesia (GSI Lab), PT Biogen Scientific, PT Genetika Medika, Selected International Gene Synthesis Providers Active in Indonesia contribute to innovation, geographic expansion, and service delivery in this space.
PT Genetika Science Indonesia
2003 Jakarta, Indonesia
PT Bio Farma (Persero)
1890 Bandung, Indonesia
PT Prodia Stem Cell Indonesia
2012 Jakarta, Indonesia
PT Kalbe Farma Tbk
1966 Jakarta, Indonesia
PT Eijkman Institute for Molecular Biology
1992 Jakarta, Indonesia
Company
Establishment Year
Headquarters
Group Size (Large, Medium, or Small as per industry convention) Indonesia Gene Synthesis Research Use Revenue (USD, Latest Year)
3-year Revenue CAGR in Indonesia Gene Synthesis Research Use (%)
Indonesia Market Share (%)
R&D Intensity (% of Revenue Spent on R&D)
Number of Active Research Customers in Indonesia
Indonesia Gene Synthesis Research Use Market Industry Analysis
Growth Drivers
Increasing Demand for Synthetic Biology Applications: The Indonesian biotechnology sector is experiencing a surge in demand for synthetic biology applications, driven by a growing need for innovative solutions in agriculture and healthcare. In future, the biotechnology sector is projected to contribute approximately IDR 57.5 trillion to the national economy, reflecting a 15% increase from the previous period. This growth is fueled by advancements in genetic engineering, which enable the development of crops with enhanced traits and personalized medical therapies, thereby expanding the market for gene synthesis. Advancements in Gene Editing Technologies: The rapid evolution of gene editing technologies, particularly CRISPR, is a significant growth driver for the gene synthesis market in Indonesia. In future, investments in gene editing research are expected to reach IDR 12 trillion, a 20% increase from the previous period. These advancements facilitate precise modifications in genetic material, enhancing research capabilities in various fields, including agriculture and medicine, and driving demand for gene synthesis services and products. Rising Investment in Biotechnology Research: Indonesia is witnessing a notable increase in investment in biotechnology research, with government funding projected to exceed IDR 10 trillion in future. This represents a 25% rise compared to the previous period. Such investments are aimed at fostering innovation and supporting research institutions, which are crucial for the development of gene synthesis technologies. The influx of capital is expected to enhance the capabilities of local firms, thereby stimulating market growth and competitiveness.
Market Challenges
High Costs Associated with Gene Synthesis: One of the primary challenges facing the gene synthesis market in Indonesia is the high cost of synthesis services, which can reach up to IDR 1.15 billion for complex projects. This financial barrier limits access for smaller research institutions and startups, hindering innovation. As the market evolves, addressing these cost issues will be essential for broadening participation and fostering a more inclusive biotechnology ecosystem. Regulatory Hurdles in Biotechnology: The regulatory landscape for biotechnology in Indonesia presents significant challenges, with compliance costs estimated at IDR 600 million per project. These hurdles can delay research and development timelines, discouraging investment in gene synthesis initiatives. Navigating the complex regulatory environment requires substantial resources, which can be particularly burdensome for emerging biotech firms, potentially stifling innovation and market growth.
Indonesia Gene Synthesis Research Use Market Future Outlook
The future of the gene synthesis market in Indonesia appears promising, driven by ongoing advancements in biotechnology and increasing collaboration between research institutions and private firms. As the government continues to support biotech initiatives, the market is likely to see enhanced innovation and the development of cost-effective synthesis methods. Additionally, the integration of artificial intelligence in gene synthesis processes is expected to streamline operations, further propelling market growth and expanding applications across various sectors.
Market Opportunities
Expansion of Research Institutions: The establishment of new research institutions in Indonesia presents a significant opportunity for the gene synthesis market. With an expected increase of 30% in research facilities in future, these institutions will drive demand for gene synthesis services, fostering innovation and collaboration within the biotechnology sector. Collaborations with International Biotech Firms: Forming partnerships with international biotech firms can enhance local capabilities and access to advanced technologies. Such collaborations are projected to increase by 40% in future, providing Indonesian companies with the expertise and resources needed to compete globally, thereby expanding the gene synthesis market.
Please Note: The report will take approximately 4–6 weeks to prepare and deliver.
Update cycle typically involves:
Dataset refresh & triangulation from credible public sources + paid databases where applicable.
Competitive mapping (platform coverage, business model, revenue/traffic proxies where available, key vertical splits)
Validation pass to ensure numbers are directionally consistent (and avoid “stale” assumptions)
Finalizing the PDF + Excel with clear assumptions and definitions.
Table of Contents
93 Pages
- 1. Indonesia Gene Synthesis Research Use Size Share Growth Drivers Trends Opportunities & – Market Overview
- 1.1. Definition and Scope
- 1.2. Market Taxonomy
- 1.3. Market Growth Rate
- 1.4. Market Segmentation Overview
- 2. Indonesia Gene Synthesis Research Use Size Share Growth Drivers Trends Opportunities & – Market Size (in USD Bn), 2019-2024
- 2.1. Historical Market Size
- 2.2. Year-on-Year Growth Analysis
- 2.3. Key Market Developments and Milestones
- 3. Indonesia Gene Synthesis Research Use Size Share Growth Drivers Trends Opportunities & – Market Analysis
- 3.1. Growth Drivers
- 3.1.1 Increasing investment in biotechnology research
- 3.1.2 Rising demand for synthetic biology applications
- 3.1.3 Expansion of pharmaceutical and agricultural sectors
- 3.1.4 Government initiatives supporting biotech innovation
- 3.2. Restraints
- 3.2.1 High costs associated with gene synthesis technologies
- 3.2.2 Limited awareness among potential end-users
- 3.2.3 Regulatory hurdles in biotechnology
- 3.2.4 Competition from alternative technologies
- 3.3. Opportunities
- 3.3.1 Growth in personalized medicine and genomics
- 3.3.2 Collaborations between academia and industry
- 3.3.3 Emerging markets for agricultural biotechnology
- 3.3.4 Advancements in CRISPR and gene editing technologies
- 3.4. Trends
- 3.4.1 Increasing adoption of automation in gene synthesis
- 3.4.2 Shift towards sustainable and eco-friendly practices
- 3.4.3 Rising focus on precision medicine
- 3.4.4 Integration of AI and machine learning in biotech research
- 3.5. Government Regulation
- 3.5.1 Regulatory frameworks for gene editing technologies
- 3.5.2 Compliance requirements for biotechnology firms
- 3.5.3 Intellectual property rights in gene synthesis
- 3.5.4 Ethical considerations in genetic research
- 3.6. SWOT Analysis
- 3.7. Stakeholder Ecosystem
- 3.8. Competition Ecosystem
- 4. Indonesia Gene Synthesis Research Use Size Share Growth Drivers Trends Opportunities & – Market Segmentation, 2024
- 4.1. By Application Area (in Value %)
- 4.1.1 Pharmaceuticals
- 4.1.2 Agriculture
- 4.1.3 Research and Development
- 4.1.4 Industrial Biotechnology
- 4.1.5 Others
- 4.2. By Service Type (in Value %)
- 4.2.1 Custom Gene Synthesis
- 4.2.2 Gene Editing Services
- 4.2.3 Gene Assembly Services
- 4.2.4 Others
- 4.3. By End-User (in Value %)
- 4.3.1 Academic Institutions
- 4.3.2 Pharmaceutical Companies
- 4.3.3 Biotech Firms
- 4.3.4 Clinical Research Organizations
- 4.4. By Pricing Model (in Value %)
- 4.4.1 Fixed Pricing
- 4.4.2 Subscription-Based Pricing
- 4.4.3 Pay-Per-Use
- 4.5. By Region (in Value %)
- 4.5.1 Java
- 4.5.2 Sumatra
- 4.5.3 Bali
- 4.5.4 Kalimantan
- 4.5.5 Sulawesi
- 4.5.6 Papua
- 4.5.7 Others
- 5. Indonesia Gene Synthesis Research Use Size Share Growth Drivers Trends Opportunities & – Market Cross Comparison
- 5.1. Detailed Profiles of Major Companies
- 5.1.1 PT Genetika Science
- 5.1.2 BioFarma
- 5.1.3 PT Bioteknologi Indonesia
- 5.1.4 PT Genomics Indonesia
- 5.1.5 PT DNA Synthesis Indonesia
- 5.2. Cross Comparison Parameters
- 5.2.1 No. of Employees
- 5.2.2 Headquarters
- 5.2.3 Inception Year
- 5.2.4 Revenue
- 5.2.5 Production Capacity
- 6. Indonesia Gene Synthesis Research Use Size Share Growth Drivers Trends Opportunities & – Market Regulatory Framework
- 6.1. Biotechnology Standards
- 6.2. Compliance Requirements and Audits
- 6.3. Certification Processes
- 7. Indonesia Gene Synthesis Research Use Size Share Growth Drivers Trends Opportunities & – Market Future Size (in USD Bn), 2025-2030
- 7.1. Future Market Size Projections
- 7.2. Key Factors Driving Future Market Growth
- 8. Indonesia Gene Synthesis Research Use Size Share Growth Drivers Trends Opportunities & – Market Future Segmentation, 2030
- 8.1. By Application Area (in Value %)
- 8.2. By Service Type (in Value %)
- 8.3. By End-User (in Value %)
- 8.4. By Pricing Model (in Value %)
- 8.5. By Region (in Value %)
- Disclaimer
- Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
